Latest Interviews
Showing 46–60 of 272 transcripts.
Clear all filters- Goldman Sachs29 min
Carl Nassib: NFL star to philanthropy entrepreneur
Former NFL player and first openly gay active player Carl Nassib leverages his platform to drive a strategic modernization of philanthropy through the Raise app, aiming to bridge the technological gap between traditional nonprofit infrastructure and a mobile-native donor base. Drawing on his experience as a Penn State Board member, Nassib advocates for comprehensive financial literacy education to prepare both college athletes in the NIL era and retiring athletes for wealth management, while predicting a massive transfer of generational wealth that will redefine future charitable giving.
- Goldman Sachs13 min
10KSB Voices Rural Advocacy Conference in DC: David Solomon with Program Graduate & Punchbowl News
David Solomon, Anna Palmer, Jenny Steffensmeyer
Goldman Sachs CEO David Solomon and small business owner Jenny Steffensmeyer discussed critical challenges facing the "10,000 Small Business Voices" program, including capital access, workforce shortages, and a significant rural artificial intelligence adoption gap. Solomon expressed optimism that a Republican-controlled administration will reduce regulatory burdens to stimulate growth, while Steffensmeyer highlighted that technological upskilling remains impossible without affordable financing. To address these disparities, the group urged Congress to deregulate small businesses, simplify SBA lending, and provide incentives to level the competitive playing field.
- Goldman Sachs26 min
Macro questions and market strength
Jan Hatzius, Dominic Wilson, Alison Nathan
Goldman Sachs economists Jan Hatzias and Dominic Wilson project that 2025 U.S. real GDP will grow by approximately 2.5% despite an effective tariff increase of 4–7 percentage points, a scenario where tailwinds continue to outweigh policy headwinds. While the Federal Reserve is anticipated to cut rates later in the year due to sticky but manageable inflation, markets remain resilient near record highs driven by strong consumer income growth and a pricing dynamic that favors offshore equities. The analysts warn that aggressive tariff implementation poses a significant tail risk for growth and bond yields, yet they maintain that the current low recession probability supports a gradual upward drift in risk assets.
- Goldman Sachs35 min
How the Florida Panthers won the Stanley Cup with CEO Matt Caldwell
CEO Matt Caldwell spearheaded the Florida Panthers' transformation from a financially struggling franchise into a Stanley Cup champion by implementing Wall Street-level financial rigor and a data-driven "grit" culture. The organization achieved this turnaround by pivoting revenue streams from traditional cable models to direct-to-consumer and Over-the-Air broadcasting while aggressively cultivating community engagement through veteran-focused initiatives and grassroots youth programs. This strategic shift not only secured the team's first championship in thirty years but also established a sustainable business model capable of thriving despite the NHL's unique salary cap constraints and the rapid evolution of sports media distribution.
- Goldman Sachs29 min
The pace of innovation in biotech: Mirador’s Mark McKenna
Former Prometheus Biosciences CEO Mark McKenna discusses the transformation of the biotech landscape from a pharma-dominated field to one driven by agile, high-risk companies like his current venture, Mirador Therapeutics, which recently secured $400 million in rapid fundraising. Drawing on his experience leading the $11 billion Merck acquisition of Prometheus, McKenna emphasizes that success now relies on leveraging generative AI for precision medicine, operating with a "speed as currency" philosophy to parallelize trials, and maintaining strategic secrecy to protect intellectual property against global competitors. The dialogue further outlines critical industry challenges, including the need to reform drug pricing models dominated by PBMs and to de-risk supply chains from over-reliance on Chinese manufacturing.
- Goldman Sachs39 min
Navy SEAL turned NASA Astronaut: Chris Cassidy’s journey from sea to space
Chris Cassidy, a former NASA Chief Astronaut and three-time spacewalker, is currently leading a $285 million fundraising campaign to construct a Museum, Monument, and Institute in Arlington, Texas, dedicated to honoring the 3,500 recipients of the Medal of Honor. Scheduled to open on March 25, the facility aims to educate the public on the "service above self" ethos of these recipients by showcasing stories of ordinary individuals performing extraordinary acts, drawing from Cassidy's unique perspective gained through two Navy SEAL deployments and three spaceflights. By shifting the focus from traditional military history to personal narratives of valor, the foundation seeks to make the achievements of Medal of Honor recipients as culturally prominent as those of professional athletes while addressing the broader challenge of fostering national appreciation for these sacrifices.
- Goldman Sachs15 min
Marc Benioff on how Salesforce is seizing on AI opportunities
Salesforce CEO Marc Benioff positions the company's new AgentForce platform as a critical industry shift designed to replace ineffective AI pilots with autonomous agents that augment existing workforces without requiring proprietary model training. By leveraging a foundational data cloud strategy, the system aims to boost revenue and operational efficiency across sales, service, and marketing while specifically addressing issues like healthcare worker burnout. With the platform set for public release next week, Benioff anticipates an immediate industry-wide adoption as clients gain the ability to deploy custom, high-performing agents that operate with significant speed and security.
- Goldman Sachs24 min
Driving Innovation in the Aviation Industry: JetBlue Founder David Neeleman
David Neeleman, Catherine Kolimas
Aviation entrepreneur David Neeleman outlines his career founding five airlines, including Azul and Breeze Airways, by leveraging a "disruptor mindset" that builds structurally defensible business models for underserved markets. His latest venture, Azul in Brazil, has transformed logistics and lifted 9,000 people out of poverty, while Breeze focuses on 125 US cities with minimal competition using a low-cost technology-centric approach. Neeleman concludes by detailing his philosophy of converting service failures into loyalty and his broader mission-driven philanthropy aimed at eradicating poverty within the aviation sector.
- Goldman Sachs20 min
Should investors worry about market concentration?
David Kostin, Owen Lamont, Alison Nathan
Strategists David Kostin and Owen Lamont converge on the projection that U.S. equity markets face a decade of sub-10% returns driven by extreme concentration and elevated valuations, though they diverge on whether the top ten stocks' dominance itself constitutes the primary risk. Kostin warns that the current 36% market cap concentration creates a negative equity risk premium and recommends shifting to equal-weighted indices, while Lamont argues that future volatility will stem from AI-driven creative destruction and mean reversion rather than portfolio structure. Both analysts acknowledge that the sustainability of the "magnificent seven's" growth and potential AI bubbles remain critical variables that could accelerate a decline in market performance over the next ten years.
- Goldman Sachs33 min
Primavera Capital’s Fred Hu on China’s economic trajectory
Following a historic equity rally triggered by unprecedented joint policy directives from China's financial regulators and top leadership, Fred Hu of Primavera Capital Group characterizes the current market upturn as a normalization phase with substantial catch-up potential. Hu anticipates that near-term fiscal stimulus will target household consumption while arguing that long-term confidence depends on structural reforms that reassure the private sector and accelerate innovation in fields where China currently lags in generative AI. Beyond immediate market dynamics, the event highlights China's undisputed leadership in green energy and a massive demographic opportunity within its 800 million-person middle class, which analysts project will soon drive private consumption to become the primary engine of national GDP growth.
- Goldman Sachs25 min
Soros Fund Management’s Dawn Fitzpatrick on the Risks and Rewards of Contrarian Views
Dawn Fitzpatrick, John Waldron
Soros Fund Management manages approximately $30 billion to fund annual social grants, utilizing a pragmatic investment framework that targets $1.3 billion to $1.7 billion in philanthropy while enforcing strict ESG red lines against primary brown energy companies. In the current macro environment of synchronized central bank cuts, the firm maintains a defensive fixed income stance by trading 10-year yields in a 3.75% to 4% range and avoids extending duration, while shifting focus toward asset-backed securities and public healthcare megatrends like GLP-1 drugs. Complementing these capital allocation strategies, leadership emphasizes intellectual honesty and disciplined patience derived from George Soros's mentorship, alongside innovative diversity initiatives that tie senior compensation to the long-term success of junior hires from underrepresented groups.
- Goldman Sachs30 min
Nvidia Founder and CEO Jensen Huang on the AI revolution
NVIDIA founder Jensen Huang details the company's strategic pivot from gaming GPUs to a dominant full-stack accelerated computing platform driven by the "magic kernels" of generative AI. This approach leverages architectural compatibility and the Blackwell architecture to deliver up to 500x speedups, enabling super-clusters that deploy in 19 days while generating a 5:1 cloud rental revenue multiplier. With demand so intense that global capacity is already sold out, the organization relies on a concentrated Asian supply chain and AI-augmented engineering to maintain its competitive moat and scale innovation annually.
- Goldman Sachs20 min
More gains ahead for US stocks?
David Kostin, Ryan Hammond, Alison Nathan
Goldman Sachs Research has raised its 2024 S&P 500 year-end target to approximately 6,000, citing an 11% earnings growth forecast for 2025 driven by solid macroeconomic data and semiconductor strength. While mega-cap technology stocks currently dominate the rally and trade at historic valuation highs, the firm identifies mid-cap equities as a key opportunity due to their 15x forward earnings multiple and superior performance track record during Federal Reserve rate cuts. Future market returns are expected to rely on fundamental earnings growth rather than further valuation expansion, though the outlook remains contingent on navigating immediate geopolitical risks and inflationary pressures that could limit further rate reductions.
- Goldman Sachs39 min
Ancestry CEO Deb Liu on leading the largest for-profit genealogy company
Deb Liu, Deborah Liu, Alex Chi
Ancestry CEO Deb Liu is reshaping the company's strategy from solo research to a shared "Me to We" experience by integrating AI tools and social features that preserve family stories before they are lost. Leveraging her background in leadership roles at Meta and PayPal, Liu champions the "fastest learner" mindset and "sponsorship" culture to dismantle barriers like imposter syndrome and the model minority myth for Asian American professionals. Her approach combines technological innovation in photo scanning and historical context reconstruction with a personal philosophy of adapting corporate success definitions to amplify diverse voices and strengthen community connections.
- Goldman Sachs10 min
Biopharma opportunities and macro challenges: A check-up on the industry
Asad Haider, Chris Shibutani, Salveen Richter, Sylvain
Major pharmaceutical and biotech leaders converged to identify GLP-1 agonists and AI integration as primary drivers for a market revised upward to $130 billion, while strategically addressing patent cliffs through aggressive external collaborations and M&A targeting metabolic and neurology assets. Although the biotech IPO window has reopened with nine clinical-stage offerings, investor sentiment remains sensitive to interest rate trajectories and the need for immediate commercial validation of AI-driven discoveries. Consequently, industry capital allocation prioritizes balancing near-term revenue generators with long-term growth catalysts to navigate complex clinical challenges in the central nervous system and cardiovascular disease sectors.